Thrombophilia risk factors: Difference between revisions
mNo edit summary |
m (→References) |
||
| Line 25: | Line 25: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:FinalQCRequired]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 18:41, 20 July 2016
|
Thrombophilia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombophilia risk factors On the Web |
|
American Roentgen Ray Society Images of Thrombophilia risk factors |
|
Risk calculators and risk factors for Thrombophilia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2]
Overview
Common risk factors in the development of acquired thrombophlias are trauma, surgery, immobility, pregnancy, estrogen-replacement therapy, and age. Common risk factors in the development of inherited thrombophilias are genetic mutations in Factor V Leiden and Prothrombin G20210A.
Risk Factors
Common risk factors in the development of acquired thrombophlias include:
Common risk factors in the development of inherited thrombophilias are genetic mutations in Factor V Leiden and Prothrombon G20210A.[1][2][3]
Please see thrombophilia classification for a list conditions associated with acquired thrombophilias, and to the page on causes of thrombophilia by organ system
References
- ↑ Cohoon KP, Heit JA (2014). "Inherited and secondary thrombophilia". Circulation. 129 (2): 254–7. doi:10.1161/CIRCULATIONAHA.113.001943. PMC 3979345. PMID 24421360.
- ↑ Seligsohn U, Lubetsky A (2001). "Genetic susceptibility to venous thrombosis". N Engl J Med. 344 (16): 1222–31. doi:10.1056/NEJM200104193441607. PMID 11309638.
- ↑ Middeldorp S (2011). "Evidence-based approach to thrombophilia testing". J Thromb Thrombolysis. 31 (3): 275–81. doi:10.1007/s11239-011-0572-y. PMC 3056012. PMID 21340752.